ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE

Abstract

The role of IL28B as predictor of response to PEG-IFN+RBV therapy in patients with HCV-associated Mixed Cryoglobulinemi

    Similar works